Sedentary Behavior Reduction in Pregnancy Intervention Study
SPRING
2 other identifiers
interventional
51
1 country
1
Brief Summary
This pilot and feasibility study will enroll newly pregnant women at risk for high sedentary behavior (SED) and elevated APO risk (n=53) and will randomize them to either a SED reduction intervention or control. Research aims include to: 1) demonstrate our ability to decrease SED and increase standing and light activity in pregnant women; 2) evaluate feasibility; and 3) gather preliminary effects on clinical outcomes including APOs, cardiometabolic risk factors, well-being, and fetal outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 23, 2021
CompletedStudy Start
First participant enrolled
October 4, 2021
CompletedFirst Posted
Study publicly available on registry
October 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedResults Posted
Study results publicly available
January 31, 2025
CompletedJanuary 31, 2025
December 1, 2024
1.5 years
September 23, 2021
December 20, 2024
December 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Sedentary Time
objectively measured using activPAL3 micro
Randomization to study completion, about 6 months
Standing
Objectively measured using activPAL3 micro
Randomization to study completion, about 6 months
Steps Per Day
Objectively measured using activPAL3 micro
Randomization to study completion, about 6 months
Secondary Outcomes (4)
Recruitment
Active recruitment phase, about 1 year
Retention
Beginning of randomization to 2nd trimester and 3rd trimester
Intervention Adherence to Behavioral Coaching Contacts
Randomization to study completion, about 6 months
Outcome Assessment Rates
Second and third trimester visit. Two participants were removed from this analysis due to miscarriage after randomization.
Study Arms (2)
Sedentary Behavior Reduction Intervention
EXPERIMENTALBiweekly virtual health coaching, height-adjustable work station, and fitbit - targetting decreasing sedentary behavior, increasing standing, and increasing steps per day. Printable information on physical activity recommendations also provided.
Usual Care Control
ACTIVE COMPARATORPrintable information on physical activity recommendations only
Interventions
Participants receive bimonthly behavioral health coaching, a sit-stand desk attachment or table, and an activity prompter if they do not already have one (e.g., fitbit, as needed).
Participants in the study will receive educational materials provided one time by email about the currently recommended physical activity during pregnancy.
Eligibility Criteria
You may qualify if:
- \<13 w 0 d pregnant
- at risk for high levels of sedentary behavior: i) work at a desk job ≥ 30 hrs per week; ii) work at a desk job \<30 hrs per week and report sitting on non-work days 1/2 the time or more; iii) do not work but report sitting 3/4 of the time or more; iv) self-reports \<6000 steps per day
- ≥1 risk factor for APO: nulliparity, history of APO, prepregnancy BMI ≥ 30 kg/m2, or age ≥35 yr
- plan to deliver at UPMC facility or willing to provide medical record release for prenatal care and birth records
You may not qualify if:
- chronic hypertension (resting blood pressure ≥140/90 mmHg or antihypertensive medication use)
- pre-gestational diabetes
- self-report of inability to walk 2 blocks or climb a flight of stairs
- other serious medical condition in pregnancy for which exercise is contraindicated (e.g., underlying cardiac disease, severe anemia, chronic bronchitis, or poorly controlled hyperthyroidism or seizure disorder)
- unable to provide physician's consent to participate
- participating in another health-related intervention study that could affect study outcomes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Pittsburghlead
- American Heart Associationcollaborator
Study Sites (1)
University of Pittsburgh, Department of Health and Human Development, 32 Oak Hill Court, Room 220
Pittsburgh, Pennsylvania, 15261, United States
Related Publications (2)
Gibbs BB, Kozai AC, McAdoo SN, Davis KD, Savidge MB, Paley JL, Hauspurg A, Catov JM. The sedentary behavior reduction in pregnancy intervention (SPRING) pilot and feasibility randomized trial. BMC Pregnancy Childbirth. 2024 Apr 11;24(1):261. doi: 10.1186/s12884-024-06474-3.
PMID: 38605328DERIVEDBarone Gibbs B, Kozai AC, McAdoo SN, Bastyr MC, Davis KD, Hauspurg A, Catov JM. Rationale, Design, and Methods for the Sedentary Behavior Reduction in Pregnancy Intervention (SPRING): Protocol for a Pilot and Feasibility Randomized Controlled Trial. JMIR Res Protoc. 2023 Jun 14;12:e48228. doi: 10.2196/48228.
PMID: 37314845DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Bethany Barone Gibbs
- Organization
- West Virginia University
Study Officials
- PRINCIPAL INVESTIGATOR
Bethany B Gibbs
University of Pittsburgh
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Research personnel conducting outcome assessments will be blinded to participant group assignment. As the participant will be receiving a behavioral intervention, both the participant and interventionist will be aware of group assignment.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 23, 2021
First Posted
October 26, 2021
Study Start
October 4, 2021
Primary Completion
March 30, 2023
Study Completion
June 30, 2023
Last Updated
January 31, 2025
Results First Posted
January 31, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share
The investigators do not have plans to share data at this time and will not be collecting biospecimens as part of this protocol. In the future, reasonable requests for de-identified data from other scientists will be considered. Such data will be shared with approval by the Study PI and other investigators, as appropriate.